Development of antisense oligonucleotide drugs to supress expression of the DUX4 protein as a therapy for Fascioscapulohumeral Muscular Dystrophy

Project: Research

Project Details

StatusFinished
Effective start/end date1/08/1431/07/18

Funding

  • Rosetrees Trust: £60,000.00
  • Rosetrees Trust: £17,000.00